Incidence of Cardiac Dysfunction After Brain Injury

Overview

Journal Med Arch

Specialty General Medicine

Date 2018 Dec 8

PMID 30524160

Citations 3

Authors

Selma Sijercic

Alisa Krdzalic

Harun Avdagic

Goran Krdzalic

Affiliations

Soon will be listed here.

Abstract

Introduction: Cardiovascular complications in patients with subarachnoid hemorrhage are considered to be a neurally mediated process rather than a manifestation of coronary artery disease.

Aim: The aim of study is to show the incidence and type cardiac complications after traumatic and spontaneous SAH.

Patients And Methods: The study had prospective character in which included 104 patients, with diagnosed subarachnoid hemorrhage (SAH), in the period from 2014 to 2017. Two groups of patients were formed. Group I: patients with SAH caused by the rupture of a brain aneurysm. Group II: patients with SAH after traumatic brain injury.

Results: Electrocardiogram (ECG) abnormalities was predominant after traumatic brain injury 74 %, with statistically significant difference atrial fibrillation 42.5 % (p = 0.043) and sinus bradycardia 31.4 % (p = 0.05). Hypertension are predominant in patients with spontaneous SAH with statistically significant difference (15 (27.7%) vs 36 (72%) p=0.034) and hypotension in group II (10 (18.5%) vs 2 (4%) p = 0.021 ) with traumatic SAH patients. The time in Intensive Care Unit (ICU) for traumatic SAH group was 6.1 ± 5.2 days and 3.9 ± 1.16 for spontaneous SAH group with statistical significance (p = 0.046). Respiratory support time was longer in traumatic SAH group (39.4 ± 23.44 vs. 15.66 ± 22.78) with p = 0.043.

Conclusion: Cardiac dysfunction in patients with subarachnoid hemorrhage are considered to be a neurally mediated process rather than a manifestation of coronary artery disease. Early treatment of cerebral injury could be reduce incidence of cardiac complications after traumatic brain injury. Cardiac dysfunction in patients with SAH is still very high, despite substantial qualitative progress in their treatment.

Citing Articles

Carbon monoxide-releasing molecule-3 ameliorates traumatic brain injury-induced cardiac dysfunctions via inhibition of pyroptosis and apoptosis.

Bai J, Sun W, Zheng W, Wang X, Bai Y Mol Cell Biochem. 2024; .

PMID: 39377871 DOI: 10.1007/s11010-024-05130-w.

Distant Organ Damage in Acute Brain Injury.

Rachfalska N, Putowski Z, Krzych L Brain Sci. 2020; 10(12).

PMID: 33371363 PMC: 7767338. DOI: 10.3390/brainsci10121019.

Decompressive Craniectomy Improves QTc Interval in Traumatic Brain Injury Patients.

Dabrowski W, Siwicka-Gieroba D, Robba C, Badenes R, Kotfis K, Schlegel T Int J Environ Res Public Health. 2020; 17(22).

PMID: 33233364 PMC: 7700327. DOI: 10.3390/ijerph17228653.

References

Zygun D, Zuege D, Boiteau P, Laupland K, Henderson E, Kortbeek J . Ventilator-associated pneumonia in severe traumatic brain injury. Neurocrit Care. 2006; 5(2):108-14. DOI: 10.1385/ncc:5:2:108. View

Ahmadian A, Mizzi A, Banasiak M, Downes K, Camporesi E, Sullebarger J . Cardiac manifestations of subarachnoid hemorrhage. Heart Lung Vessel. 2013; 5(3):168-78. PMC: 3848675. View

Brouwers P, Wijdicks E, Hasan D, Vermeulen M, Wever E, Frericks H . Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989; 20(9):1162-7. DOI: 10.1161/01.str.20.9.1162. View

Macrea L, Tramer M, Walder B . Spontaneous subarachnoid hemorrhage and serious cardiopulmonary dysfunction--a systematic review. Resuscitation. 2005; 65(2):139-48. DOI: 10.1016/j.resuscitation.2004.11.010. View

Wybraniec M, Mizia-Stec K, Krzych L . Neurocardiogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamin-mediated brain-heart interactions. Cardiol J. 2014; 21(3):220-8. DOI: 10.5603/CJ.a2014.0019. View

Bulsara K, McGirt M, Liao L, Villavicencio A, Borel C, Alexander M . Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98(3):524-8. DOI: 10.3171/jns.2003.98.3.0524. View

Petruk K, West M, Mohr G, Weir B, Benoit B, Gentili F . Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988; 68(4):505-17. DOI: 10.3171/jns.1988.68.4.0505. View

Lorsheyd A, Simmers T, Robles De Medina E . The relationship between electrocardiographic abnormalities and location of the intracranial aneurysm in subarachnoid hemorrhage. Pacing Clin Electrophysiol. 2003; 26(8):1722-8. DOI: 10.1046/j.1460-9592.2003.t01-1-00258.x. View

Zhang L, Qi S . Electrocardiographic Abnormalities Predict Adverse Clinical Outcomes in Patients with Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis. 2016; 25(11):2653-2659. DOI: 10.1016/j.jstrokecerebrovasdis.2016.07.011. View

10.

Naidech A, Kreiter K, Janjua N, Ostapkovich N, Parra A, Commichau C . Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005; 112(18):2851-6. DOI: 10.1161/CIRCULATIONAHA.105.533620. View

11.

Okabe T, Kanzaria M, Rincon F, Kraft W . Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role?. Neurocrit Care. 2012; 18(2):271-84. DOI: 10.1007/s12028-012-9804-z. View

12.

Huang C, Huang C, Kuo H, Chan C, Chen J, Chen W . The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication. Am J Emerg Med. 2011; 30(5):732-6. DOI: 10.1016/j.ajem.2011.05.003. View

13.

Lanzino G, Kongable G, Kassell N . Electrocardiographic abnormalities after nontraumatic subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1994; 6(3):156-62. DOI: 10.1097/00008506-199407000-00002. View

14.

Urbaniak K, Merchant A, Amin-Hanjani S, Roitberg B . Cardiac complications after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007; 67(1):21-8. DOI: 10.1016/j.surneu.2006.08.065. View

15.

Banki N, Kopelnik A, Dae M, Miss J, Tung P, Lawton M . Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005; 112(21):3314-9. DOI: 10.1161/CIRCULATIONAHA.105.558239. View